Fulltext

Impact of clinical features on the efficacy of osimertinib treatment in epidermal growth factor receptor mutant non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors due to T790M mutation

Liam CK 1 , Poh ME 1 , Liam YS 2

Affiliations 

  • 1 Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 2 Clinical Investigation Centre, University Malaya Medical Centre, Kuala Lumpur, Malaysia
J Thorac Dis, 2019 Sep;11(Suppl 15):S1847-S1851.
PMID: 31632766 DOI: 10.21037/jtd.2019.08.117

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications